Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry (2022)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1016/j.jjcc.2021.10.024
- Subjects: VASOS CORONÁRIOS; INFARTO DO MIOCÁRDIO; FÁRMACOS SINTÉTICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of cardiology
- ISSN: 0914-5087
- Volume/Número/Paginação/Ano: v. 79, n. 4, p. 522-529, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
RUSSO, Juan J et al. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry. Journal of cardiology, v. 79, n. 4, p. 522-529, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jjcc.2021.10.024. Acesso em: 24 jan. 2026. -
APA
Russo, J. J., Yan, A. T., Pocock, S. J., Brieger, D., Owen, R., Sundell, K. A., et al. (2022). Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry. Journal of cardiology, 79( 4), 522-529. doi:10.1016/j.jjcc.2021.10.024 -
NLM
Russo JJ, Yan AT, Pocock SJ, Brieger D, Owen R, Sundell KA, Bagai A, Granger CB, Cohen MG, Nicolau JC. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry [Internet]. Journal of cardiology. 2022 ; 79( 4): 522-529.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1016/j.jjcc.2021.10.024 -
Vancouver
Russo JJ, Yan AT, Pocock SJ, Brieger D, Owen R, Sundell KA, Bagai A, Granger CB, Cohen MG, Nicolau JC. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry [Internet]. Journal of cardiology. 2022 ; 79( 4): 522-529.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1016/j.jjcc.2021.10.024 - P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes
- Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction
- Doença arterial coronariana aguda
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
- Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor for the prevention of ischemic events in patients with prior myocardial infarction and peripheral artery disease
- Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
Informações sobre o DOI: 10.1016/j.jjcc.2021.10.024 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
